MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    First Results from the Ixcellence Network® Survey: Botulinum Neurotoxin-A Usage and Training in Cervical Dystonia & Spastic Paresis

    R. Bhidayasiri, K. Bahtia, L.J. Jacinto, TM. Chung, T. Landreau, C. Colosimo (Bangkok, Thailand)

    Objective: To describe the current situation of training and practices among physicians using botulinum neurotoxin-A (BoNT-A) injections in the treatment of Cervical Dystonia (CD) and…
  • 2018 International Congress

    Hereditary spastic paraplegia presenting as limb dystonia with a novel SPG7 mutation

    S. Schaefer, J. Moeller, S. Tinaz (New Haven, CT, USA)

    Objective: We present a case of a patient who presented with limb dystonia and was found to have HSP associated with a previously unreported compound…
  • 2018 International Congress

    Clinical and genetic heterogeneity in portuguese patients with Hereditary Spastic Paraplegia

    I. Cunha, A. Brás, J. Ribeiro, C. Januário (Coimbra, Portugal)

    Objective: To characterize the demographic, clinical and genetic features of HSP and to define the phenotypic spectrum and genotype-specific differences. Background: Hereditary spastic paraplegia (HSP)…
  • 2018 International Congress

    The nigral hyperintensity on 3 Tesla susceptibility-weighted MRI in patients with vascular parkinsonism

    K.J. Kim, Y.J. Bae, J.M. Kim, S.E. Kim, B.S. Jeon (Goyang, Republic of Korea)

    Objective: Previously, the loss of nigral hyperintensity on 3 Tesla susceptibility-weighted MR imaging (3T-SWI) in patients with PD has been reported. In this study, the…
  • 2018 International Congress

    The impact of thalamic lesions on visuomotor behavior: A behavioral and fMRI study

    M. Wilke, C. Schmidt-Samoa, P. Dechent, K. Miloserdov, J. Liman, M. Holzgraefe, I. Kagan, M. Bähr (Goettingen, Germany)

    Objective: Analysis of thalamic lesion-induced deficits on oculomotor and reaching behaviour: a psychophysical and fMRI study Background: Lesion studies and cortical connectivity suggest that higher-order…
  • 2018 International Congress

    Artisanal formulations of Cannabis in Movement Disorders. The real-life perspective in a population from Buenos Aires, Argentina. Preliminary report

    M. Cesarini, JL. Etcheverry, N. Gonzalez Rojas, G. Da Prat, V. Parisi, G. Rojas, G. Persi, E. Gatto (Buenos Aires, Argentina)

    Objective: To describe the effect of artisanal formulations of CBDo in a retrospective case series of patients with a variable spectrum of movement disorders, who…
  • 2018 International Congress

    Neuroprotective Effects of A Combination of Curcumin and Mucuna Prurience in Rotenone Induced Mice Model of Parkinson’s Disease

    M. Panchwadkar, P. Rane, D. Khatri, V. Undale (Pune, India)

    Objective: In the current study we have evaluated possible synergistic neuroprotective effect of two Poly-Phenols from Curcumin and Mucuna Prurience. The combine treatment of Curcumin…
  • 2018 International Congress

    The use of gliatilin in the complex treatment of vascular parkinsonism

    S. Lukmonov, D. Tolibov (Tashkent, Uzbekistan)

    Objective: In recent decades, as a result of increasing the life expectancy of the population, the number of patients with Parkinsonism has increased, which leads…
  • 2018 International Congress

    Gait speed after applying anodal-transcranial Direct Current Stimulation in people with Parkinson’s disease? Preliminary results

    V. Alizad, M. Meinzer, L. Frossard, R. Polman, S. Smith, G. Kerr (Brisbane, Australia)

    Objective: The objective of this study was to explore the effects of anodal-tDCS with two different montages on gait speed in people with PD. Background:…
  • 2018 International Congress

    Long-Duration Response to Levodopa in advanced Parkinson’s Disease: Relevance for RCT on Disease-Modifying therapies

    R. Cilia, E. Cereda, A. Akpalu, S. Sarfo, M. Cham, G. Pezzoli (Milan, Italy)

    Objective: (1) To investigate the natural history of Parkinson’s disease (PD) in a cohort of newly diagnosed patients and (2) the response to acute levodopa…
  • « Previous Page
  • 1
  • …
  • 154
  • 155
  • 156
  • 157
  • 158
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley